Evolent Health (EVH) Debt to Equity (2019 - 2026)

Evolent Health has reported Debt to Equity for 8 years, with the latest figure at $2.46 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity rose 180.41% year-over-year to $2.46; the trailing twelve-month figure through Mar 2026 stood at $2.46 (up 180.41% YoY), and the FY2025 full-year result was $2.34, up 253.56% from the prior year.
• Debt to Equity for Q1 2026 stood at $2.46, up from $2.34 in the prior quarter.
• The five-year high for Debt to Equity was $2.46 in Q1 2026, with the low at $0.46 in Q2 2022.
• Average Debt to Equity over 5 years is $0.84, with a median of $0.57 recorded in 2024.
• Year-over-year, Debt to Equity decreased 1.87% in 2024 and surged 253.56% in 2025.
• Tracing EVH's Debt to Equity over 5 years: stood at $0.48 in 2022, then rose by 16.37% to $0.56 in 2023, then rose by 18.23% to $0.66 in 2024, then surged by 253.56% to $2.34 in 2025, then grew by 5.06% to $2.46 in 2026.
• The last three Debt to Equity figures came in at $2.46 (Q1 2026), $2.34 (Q4 2025), and $1.26 (Q3 2025), per Business Quant data.

Peer Comparison